Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study.

Endocrinology and metabolism (Seoul, Korea)

Song E, Koo MJ, Noh E, Hwang SY, Park MJ, Kim JA, Roh E, Choi KM, Baik SH, Cho GJ, Yoo HJ.
PMID: 34915605
Endocrinol Metab (Seoul). 2021 Dec 16; doi: 10.3803/EnM.2021.1251. Epub 2021 Dec 16.

BACKGROUND: The detrimental effects of excessive thyroid hormone on glucose metabolism have been widely investigated. However, the risk of diabetes in patients with long-standing hyperthyroidism, especially according to treatment modality, remains uncertain, with few longitudinal studies.METHODS: The risk of...

Cite
Song E, Koo MJ, Noh E, et al. Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study. Endocrinol Metab (Seoul). 2021;doi: 10.3803/EnM.2021.1251.
Song, E., Koo, M. J., Noh, E., Hwang, S. Y., Park, M. J., Kim, J. A., Roh, E., Choi, K. M., Baik, S. H., Cho, G. J., & Yoo, H. J. (2021). Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study. Endocrinology and metabolism (Seoul, Korea), . https://doi.org/10.3803/EnM.2021.1251
Song, Eyun, et al. "Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study." Endocrinology and metabolism (Seoul, Korea) vol. (2021). doi: https://doi.org/10.3803/EnM.2021.1251
Song E, Koo MJ, Noh E, Hwang SY, Park MJ, Kim JA, Roh E, Choi KM, Baik SH, Cho GJ, Yoo HJ. Risk of Diabetes in Patients with Long-Standing Graves' Disease: A Longitudinal Study. Endocrinol Metab (Seoul). 2021 Dec 16; doi: 10.3803/EnM.2021.1251. Epub 2021 Dec 16. PMID: 34915605.
Copy Download .nbib Format: NLM
Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department.

Diagnostics (Basel, Switzerland)

Bilha S, Mitu O, Teodoriu L, Haba C, Preda C.
PMID: 32443393
Diagnostics (Basel). 2020 May 18;10(5). doi: 10.3390/diagnostics10050316.

Despite its' life-threatening potential due to cardiac severe dysrhythmia in the context of severe hypokalemia, thyrotoxic periodic paralysis (TPP) often goes unrecognized. Although classically confined to young Asian men, it can occur irrespective of age, sex, and race. We...

Cite
Bilha S, Mitu O, Teodoriu L, et al. Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department. Diagnostics (Basel). 2020;10(5)doi: 10.3390/diagnostics10050316.
Bilha, S., Mitu, O., Teodoriu, L., Haba, C., & Preda, C. (2020). Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department. Diagnostics (Basel, Switzerland), 10(5), . https://doi.org/10.3390/diagnostics10050316
Bilha, Stefana, et al. "Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department." Diagnostics (Basel, Switzerland) vol. 10,5 (2020). doi: https://doi.org/10.3390/diagnostics10050316
Bilha S, Mitu O, Teodoriu L, Haba C, Preda C. Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department. Diagnostics (Basel). 2020 May 18;10(5). doi: 10.3390/diagnostics10050316. PMID: 32443393; PMCID: PMC7277936.
Copy Download .nbib Format: NLM
Antithyroid Drug Treatment in Graves' Disease.

Endocrinology and metabolism (Seoul, Korea)

Chung JH.
PMID: 34130446
Endocrinol Metab (Seoul). 2021 Jun;36(3):491-499. doi: 10.3803/EnM.2021.1070. Epub 2021 Jun 16.

Graves' disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence after antithyroid drug (ATD)...

Cite
Chung JH. Antithyroid Drug Treatment in Graves' Disease. Endocrinol Metab (Seoul). 2021;36(3):491-499doi: 10.3803/EnM.2021.1070.
Chung, J. H. (2021). Antithyroid Drug Treatment in Graves' Disease. Endocrinology and metabolism (Seoul, Korea), 36(3), 491-499. https://doi.org/10.3803/EnM.2021.1070
Chung, Jae Hoon. "Antithyroid Drug Treatment in Graves' Disease." Endocrinology and metabolism (Seoul, Korea) vol. 36,3 (2021): 491-499. doi: https://doi.org/10.3803/EnM.2021.1070
Chung JH. Antithyroid Drug Treatment in Graves' Disease. Endocrinol Metab (Seoul). 2021 Jun;36(3):491-499. doi: 10.3803/EnM.2021.1070. Epub 2021 Jun 16. PMID: 34130446; PMCID: PMC8258321.
Copy Download .nbib Format: NLM
Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis.

Case reports in endocrinology

Sanjari M, Shakibi M, Safavi M.
PMID: 34123438
Case Rep Endocrinol. 2021 May 22;2021:6669653. doi: 10.1155/2021/6669653. eCollection 2021.

Graves' disease is the most common cause of hyperthyroidism, which is characterized by thyroid antibodies and the following clinical manifestations: goiter, ophthalmopathy, and pretibial myxedema. On the other hand, Henoch-Schönlein purpura is an IgA-mediated small-vessel vasculitis. Review of the...

Cite
Sanjari M, Shakibi M, Safavi M. Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis. Case Rep Endocrinol. 2021;2021:6669653doi: 10.1155/2021/6669653.
Sanjari, M., Shakibi, M., & Safavi, M. (2021). Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis. Case reports in endocrinology, 20216669653. https://doi.org/10.1155/2021/6669653
Sanjari, Mojgan, et al. "Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis." Case reports in endocrinology vol. 2021 (2021): 6669653. doi: https://doi.org/10.1155/2021/6669653
Sanjari M, Shakibi M, Safavi M. Henoch-Schönlein Purpura (IgA Vasculitis) in Association with Thyrotoxicosis. Case Rep Endocrinol. 2021 May 22;2021:6669653. doi: 10.1155/2021/6669653. eCollection 2021. PMID: 34123438; PMCID: PMC8166464.
Copy Download .nbib Format: NLM
A comparison of cultured rat FRTL-5 and porcine thyroid cells for predicting the thyroid toxicity of xenobiotics.

Toxicology in vitro : an international journal published in association with BIBRA

Atterwill CK, Fowler KF.
PMID: 20702196
Toxicol In Vitro. 1990;4(4):369-74. doi: 10.1016/0887-2333(90)90082-5.

Two commonly used cell culture systems are currently available for testing the effects of xenobiotics on thyroid cell function and growth. These are the rat FRTL-5 thyroid cell line and the primary, cultured porcine thyrocyte. Both systems have inherent...

Cite
Atterwill CK, Fowler KF. A comparison of cultured rat FRTL-5 and porcine thyroid cells for predicting the thyroid toxicity of xenobiotics. Toxicol In Vitro. 1990;4(4):369-74doi: 10.1016/0887-2333(90)90082-5.
Atterwill, C. K., & Fowler, K. F. (1990). A comparison of cultured rat FRTL-5 and porcine thyroid cells for predicting the thyroid toxicity of xenobiotics. Toxicology in vitro : an international journal published in association with BIBRA, 4(4), 369-74. https://doi.org/10.1016/0887-2333(90)90082-5
Atterwill, C K, and Fowler, K F. "A comparison of cultured rat FRTL-5 and porcine thyroid cells for predicting the thyroid toxicity of xenobiotics." Toxicology in vitro : an international journal published in association with BIBRA vol. 4,4 (1990): 369-74. doi: https://doi.org/10.1016/0887-2333(90)90082-5
Atterwill CK, Fowler KF. A comparison of cultured rat FRTL-5 and porcine thyroid cells for predicting the thyroid toxicity of xenobiotics. Toxicol In Vitro. 1990;4(4):369-74. doi: 10.1016/0887-2333(90)90082-5. PMID: 20702196.
Copy Download .nbib Format: NLM
Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea.

Endocrinology and metabolism (Seoul, Korea)

Kim HK, Yoon JH, Jeon MJ, Kim TY, Shong YK, Lee MJ, Kim BH, Kim IJ, Joung JY, Kim SW, Chung JH, Kang HC.
PMID: 26394729
Endocrinol Metab (Seoul). 2015 Dec;30(4):475-80. doi: 10.3803/EnM.2015.30.4.475. Epub 2015 Sep 22.

BACKGROUND: Antithyroid drugs (ATDs) can lead to the development of agranulocytosis, which is the most serious adverse effect. Characteristics of ATD-induced agranulocytosis (AIA) have seldom been reported due to the rarity. In this study, we characterized the clinical features...

Cite
Kim HK, Yoon JH, Jeon MJ, et al. Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea. Endocrinol Metab (Seoul). 2015;30(4):475-80doi: 10.3803/EnM.2015.30.4.475.
Kim, H. K., Yoon, J. H., Jeon, M. J., Kim, T. Y., Shong, Y. K., Lee, M. J., Kim, B. H., Kim, I. J., Joung, J. Y., Kim, S. W., Chung, J. H., & Kang, H. C. (2015). Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea. Endocrinology and metabolism (Seoul, Korea), 30(4), 475-80. https://doi.org/10.3803/EnM.2015.30.4.475
Kim, Hee Kyung, et al. "Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea." Endocrinology and metabolism (Seoul, Korea) vol. 30,4 (2015): 475-80. doi: https://doi.org/10.3803/EnM.2015.30.4.475
Kim HK, Yoon JH, Jeon MJ, Kim TY, Shong YK, Lee MJ, Kim BH, Kim IJ, Joung JY, Kim SW, Chung JH, Kang HC. Characteristics of Korean Patients with Antithyroid Drug-Induced Agranulocytosis: A Multicenter Study in Korea. Endocrinol Metab (Seoul). 2015 Dec;30(4):475-80. doi: 10.3803/EnM.2015.30.4.475. Epub 2015 Sep 22. PMID: 26394729; PMCID: PMC4722401.
Copy Download .nbib Format: NLM
Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves' disease under methimazole therapy: A Case report.

Mediterranean journal of rheumatology

Nikitopoulou E, Gazi S.
PMID: 32185299
Mediterr J Rheumatol. 2018 Mar 19;29(1):52-54. doi: 10.31138/mjr.29.1.52. eCollection 2018 Mar.

We report the case of a 40-year-old Greek female with symptoms of polyarthritis, pruritic rash and positive p-ANCA antibodies, undergoing treatment with Methimazole therapy for Graves' disease. The rash and the arthritis symptoms promptly disappeared after withdrawal of methimazole,...

Cite
Nikitopoulou E, Gazi S. Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves' disease under methimazole therapy: A Case report. Mediterr J Rheumatol. 2018;29(1):52-54doi: 10.31138/mjr.29.1.52.
Nikitopoulou, E., & Gazi, S. (2018). Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves' disease under methimazole therapy: A Case report. Mediterranean journal of rheumatology, 29(1), 52-54. https://doi.org/10.31138/mjr.29.1.52
Nikitopoulou, Eleni, and Gazi, Sousana. "Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves' disease under methimazole therapy: A Case report." Mediterranean journal of rheumatology vol. 29,1 (2018): 52-54. doi: https://doi.org/10.31138/mjr.29.1.52
Nikitopoulou E, Gazi S. Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves' disease under methimazole therapy: A Case report. Mediterr J Rheumatol. 2018 Mar 19;29(1):52-54. doi: 10.31138/mjr.29.1.52. eCollection 2018 Mar. PMID: 32185299; PMCID: PMC7045956.
Copy Download .nbib Format: NLM
Predicting relapse of Graves' disease following treatment with antithyroid drugs.

Experimental and therapeutic medicine

Liu L, Lu H, Liu Y, Liu C, Xun C.
PMID: 27073464
Exp Ther Med. 2016 Apr;11(4):1453-1458. doi: 10.3892/etm.2016.3058. Epub 2016 Feb 09.

The aim of the present study was to monitor long term antithyroid drug treatments and to identify prognostic factors for Graves' disease (GD). A total of 306 patients with GD who were referred to the Endocrinology Clinic at Weifang...

Cite
Liu L, Lu H, Liu Y, et al. Predicting relapse of Graves' disease following treatment with antithyroid drugs. Exp Ther Med. 2016;11(4):1453-1458doi: 10.3892/etm.2016.3058.
Liu, L., Lu, H., Liu, Y., Liu, C., & Xun, C. (2016). Predicting relapse of Graves' disease following treatment with antithyroid drugs. Experimental and therapeutic medicine, 11(4), 1453-1458. https://doi.org/10.3892/etm.2016.3058
Liu, Lin, et al. "Predicting relapse of Graves' disease following treatment with antithyroid drugs." Experimental and therapeutic medicine vol. 11,4 (2016): 1453-1458. doi: https://doi.org/10.3892/etm.2016.3058
Liu L, Lu H, Liu Y, Liu C, Xun C. Predicting relapse of Graves' disease following treatment with antithyroid drugs. Exp Ther Med. 2016 Apr;11(4):1453-1458. doi: 10.3892/etm.2016.3058. Epub 2016 Feb 09. PMID: 27073464; PMCID: PMC4812122.
Copy Download .nbib Format: NLM
Surgical management of an atypical presentation of a thyroid storm.

International journal of endocrinology and metabolism

Aulet RM, Wein RO, Siegel RD.
PMID: 24782903
Int J Endocrinol Metab. 2014 Apr 01;12(2):e13539. doi: 10.5812/ijem.13539. eCollection 2014 Apr.

INTRODUCTION: Thyroid storm is a rare complication of Graves' disease that can carry a poor prognosis. In order to prevent major complications, thyroid storm must be quickly identified in patients and treatment must be promptly implemented. Medical treatment is...

Cite
Aulet RM, Wein RO, Siegel RD. Surgical management of an atypical presentation of a thyroid storm. Int J Endocrinol Metab. 2014;12(2):e13539doi: 10.5812/ijem.13539.
Aulet, R. M., Wein, R. O., & Siegel, R. D. (2014). Surgical management of an atypical presentation of a thyroid storm. International journal of endocrinology and metabolism, 12(2), e13539. https://doi.org/10.5812/ijem.13539
Aulet, Ricardo Mario, et al. "Surgical management of an atypical presentation of a thyroid storm." International journal of endocrinology and metabolism vol. 12,2 (2014): e13539. doi: https://doi.org/10.5812/ijem.13539
Aulet RM, Wein RO, Siegel RD. Surgical management of an atypical presentation of a thyroid storm. Int J Endocrinol Metab. 2014 Apr 01;12(2):e13539. doi: 10.5812/ijem.13539. eCollection 2014 Apr. PMID: 24782903; PMCID: PMC3997950.
Copy Download .nbib Format: NLM
An overview on the proposed mechanisms of antithyroid drugs-induced liver injury.

Advanced pharmaceutical bulletin

Heidari R, Niknahad H, Jamshidzadeh A, Eghbal MA, Abdoli N.
PMID: 25789213
Adv Pharm Bull. 2015 Mar;5(1):1-11. doi: 10.5681/apb.2015.001. Epub 2015 Mar 05.

Drug-induced liver injury (DILI) is a major problem for pharmaceutical industry and drug development. Mechanisms of DILI are many and varied. Elucidating the mechanisms of DILI will allow clinicians to prevent liver failure, need for liver transplantation, and death...

Cite
Heidari R, Niknahad H, Jamshidzadeh A, et al. An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv Pharm Bull. 2015;5(1):1-11doi: 10.5681/apb.2015.001.
Heidari, R., Niknahad, H., Jamshidzadeh, A., Eghbal, M. A., & Abdoli, N. (2015). An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Advanced pharmaceutical bulletin, 5(1), 1-11. https://doi.org/10.5681/apb.2015.001
Heidari, Reza, et al. "An overview on the proposed mechanisms of antithyroid drugs-induced liver injury." Advanced pharmaceutical bulletin vol. 5,1 (2015): 1-11. doi: https://doi.org/10.5681/apb.2015.001
Heidari R, Niknahad H, Jamshidzadeh A, Eghbal MA, Abdoli N. An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv Pharm Bull. 2015 Mar;5(1):1-11. doi: 10.5681/apb.2015.001. Epub 2015 Mar 05. PMID: 25789213; PMCID: PMC4352210.
Copy Download .nbib Format: NLM
Hemodynamic Instability during Thyroidectomy in Graves' Disease.

Journal of investigative surgery : the official journal of the Academy of Surgical Research

Acar S, Ercetin C, Sahbaz NA, Tutal F, Yapalak Y, Cosan F, Erbil Y.
PMID: 33908335
J Invest Surg. 2021 Apr 28;1-5. doi: 10.1080/08941939.2021.1914785. Epub 2021 Apr 28.

BACKGROUND: The aim of this study was to investigate the changes in vital signs and hemodynamic status that occur in patients during the intraoperative course of thyroidectomy in Graves' Disease (GD).METHODS: A total of 71 patients were included in...

Cite
Acar S, Ercetin C, Sahbaz NA, et al. Hemodynamic Instability during Thyroidectomy in Graves' Disease. J Invest Surg. 2021;1-5doi: 10.1080/08941939.2021.1914785.
Acar, S., Ercetin, C., Sahbaz, N. A., Tutal, F., Yapalak, Y., Cosan, F., & Erbil, Y. (2021). Hemodynamic Instability during Thyroidectomy in Graves' Disease. Journal of investigative surgery : the official journal of the Academy of Surgical Research, 1-5. https://doi.org/10.1080/08941939.2021.1914785
Acar, Sami, et al. "Hemodynamic Instability during Thyroidectomy in Graves' Disease." Journal of investigative surgery : the official journal of the Academy of Surgical Research vol. (2021): 1-5. doi: https://doi.org/10.1080/08941939.2021.1914785
Acar S, Ercetin C, Sahbaz NA, Tutal F, Yapalak Y, Cosan F, Erbil Y. Hemodynamic Instability during Thyroidectomy in Graves' Disease. J Invest Surg. 2021 Apr 28;1-5. doi: 10.1080/08941939.2021.1914785. Epub 2021 Apr 28. PMID: 33908335.
Copy Download .nbib Format: NLM
Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves' Disease.

Journal of the ASEAN Federation of Endocrine Societies

Wijaya N, Ong-Ramos C.
PMID: 33442144
J ASEAN Fed Endocr Soc. 2019;34(1):99-102. doi: 10.15605/jafes.034.01.16. Epub 2019 May 21.

A 34-year-old female Filipino with Graves' disease on methimazole came in due to fever, sore throat and jaundice. She was initially diagnosed with methimazole-induced agranulocytosis and drug-induced liver injury. She was treated with intravenous broad-spectrum antibiotic and granulocyte colony...

Cite
Wijaya N, Ong-Ramos C. Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves' Disease. J ASEAN Fed Endocr Soc. 2019;34(1):99-102doi: 10.15605/jafes.034.01.16.
Wijaya, N., & Ong-Ramos, C. (2019). Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves' Disease. Journal of the ASEAN Federation of Endocrine Societies, 34(1), 99-102. https://doi.org/10.15605/jafes.034.01.16
Wijaya, Natalia, and Ong-Ramos, Celeste. "Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves' Disease." Journal of the ASEAN Federation of Endocrine Societies vol. 34,1 (2019): 99-102. doi: https://doi.org/10.15605/jafes.034.01.16
Wijaya N, Ong-Ramos C. Methimazole-Induced Aplastic Anemia with Concomitant Hepatitis in a Young Filipina with Graves' Disease. J ASEAN Fed Endocr Soc. 2019;34(1):99-102. doi: 10.15605/jafes.034.01.16. Epub 2019 May 21. PMID: 33442144; PMCID: PMC7784141.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries